# OnCo record surface-oncology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/surface-oncology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "surface-oncology" ;
  schema:name "Surface Oncology"@en ;
  schema:alternateName "Surface Oncology, Inc."@en ;
  schema:description "Surface Oncology made antibodies meant to break down the defences tumours build around themselves against the immune system. Coherus BioSciences bought it in 2023."@en ;
  schema:url <https://onco.cc/companies/surface-oncology/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1512762/000155837023015582/chrs-20230908xex99d1.htm>, <https://atlasventure.com/portfolio/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> .
